slides · global inventory
Other
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 19,048
Current window 10,351-10,380
Pages 635
Rows per page 30
Slide type
10,351-10,380 of 19,048
19
The slide features photos of a lion dance, a Trunk or Treat event, and a holiday event with Santa.Flushing Financial | Results Presentation Deck | 39 slides · Flushing Financial Corporation
Conference presentation Investor relations Beat · KPI Overview1 hit
11
The slide uses a combination of a table for market share, a bar chart for relative scale, a donut chart for revenue mix, and a circular diagram to explain the business flywheel.Flutter | Securities Offering Presentation Deck | 30 slides · Flutter Entertainment
Pitch deck Investor relations Beat · Product1 hit
16
Uses a causal chain/process flow structure to link inputs to outputs.Flutter | Securities Offering Presentation Deck | 30 slides · Flutter Entertainment
Pitch deck Investor relations 1 hit
17
The slide uses a process-like flow from left to right, showing the integration of a local brand into the Flutter ecosystem.Flutter | Securities Offering Presentation Deck | 30 slides · Flutter Entertainment
Pitch deck Investor relations 1 hit
30
The slide uses a logo-grid to demonstrate the corporate structure of HTLF.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations 1 hit
35
The slide uses a logo-grid to demonstrate the corporate structure of HTLF.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations 1 hit
05
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Situation & Context1 hit
06
Includes a biological process diagram showing B-cell development and target markers (CD19, CD20, BCMA).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations 1 hit
10
The slide uses a schematic diagram to map specific protein domains to their functional benefits.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
11
Includes citations from Nature Signal Transduction and Targeted Therapy and Nature Medicine.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
17
Includes comparative data points for CAR-T characteristics.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
18
The chart illustrates the pharmacokinetics of the NXC-201 (HBI0101) therapy, highlighting a 30-day clearance window.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach1 hit
37
The chart illustrates deepening responses in patients treated with NXC-201 over time.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
38
The slide uses a combination of biological pathway diagrams, pharmacokinetic data, and efficacy metrics to demonstrate the therapeutic advantage of IMX-110.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
42
The slide uses a process flow diagram to illustrate dose escalation steps.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
50
Includes a process flow diagram illustrating the mechanism of action of iMX-110 in tumor microenvironments.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
57
Includes two sets of charts: tumor volume line charts and survival curves.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
60
Immix Biopharma | Investor Presentation Deck | 64 slidesImmix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
61
The slide uses a process-flow style layout to connect platform capabilities to specific product outputs.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
62
The process is presented as a non-linear, snake-like flow (1-5 left-to-right, 6-10 right-to-left).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
63
The slide uses a 3-pillar framework to categorize the platform's foundation, leading to specific product applications.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps1 hit
25
Includes a stacked bar chart showing hedge actions by quarter and a table summarizing the hedge portfolio.KeyCorp | Results Presentation Deck | 30 slides · KeyCorp
Conference presentation Investor relations Beat · DevelopmentLoop · Before After1 hit
05
Includes a world map background with regional revenue/employee distribution bar and list of office locations.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a split-layout: a table for AUM breakdown by asset class on the left and a timeline of team additions on the right.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · TeamLoop · Hypothesis Test1 hit
28
The diagram uses a hub-and-spoke circular flow model to represent capital allocation.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Financials1 hit
10
The slide uses a three-column layout to categorize facilities by region.Legend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations 1 hit
11
The slide details three distinct manufacturing initiatives: the Obelisc facility in Ghent, J&J in-house Lentivirus production, and a CMO partnership with Novartis.Legend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations 1 hit
12
Legend Biotech | Investor Presentation Deck | 14 slidesLegend Biotech | Investor Presentation Deck | 14 slides · Legend Biotech
Conference presentation Investor relations 1 hit
07
The slide uses a logo-grid to demonstrate market reach across four key distribution segments.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
16
Slide 16 of a presentation deck.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Loop · Cost Of Inaction1 hit